Latest News & Features
Americas
There are several rules to watch out for when seeking patent protection for antibodies in Brazil, as Kene Gallois of Daniel Advogados reports. 8 June 2016
Africa
The president of Nigeria’s Senate has proposed that people convicted of selling counterfeit drugs and food are jailed for life and fined up to ₦2 million dollars. 7 June 2016
Americas
Merial, which is well-known for making products that kill fleas and ticks on cats and dogs, faces a number of challenges on the IP front, as global head of IP Dr Judy Jarecki-Black, tells LSIPR. 7 June 2016
Biotechnology
LSIPR spoke to Dr Claire Skentelbery of the ENABLE project about the need for novel developments and the importance of a solid intellectual property strategy. 7 June 2016
Africa
For something to be innovative it must “add value” and companies must ensure they understand the term in order to succeed, the 2016 BIO International Convention has heard. 7 June 2016
Americas
The 2016 BIO International Convention has heard that drug companies are on a mission to discover new tools to support the development of anti-infectives due to a decrease in the development of new antibiotics. 7 June 2016
Americas
The 2016 BIO International Convention kicked off in style Monday night with an evening of scientific discovery at the Exploratorium. 7 June 2016
Big Pharma
EPO case law suggests that inventions covering homeopathic medicines do not have to meet a higher bar of patentability than conventional medicaments, but it still must be shown that the claimed products lead to the alleged therapeutic effect. André Guder of Uexküll & Stolberg reports. 7 June 2016
Americas
Applicants wishing to extend their patents’ term of protection do not have to necessarily match up the wording of the claims and the label of the relevant drug for there to be infringement by an ANDA, as MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch reports. 7 June 2016
Americas
Pharmaceutical company AstraZeneca has agreed a licensing deal with German drug maker Grünenthal centring on gout treatment drug Zurampic. 6 June 2016